Dupilumab for the Treatment of Chronic Spontaneous Urticaria in Patients Who Remain Symptomatic Despite the Use of H1 Antihistamine and Who Are naïve to, Intolerant of, or Incomplete Responders to Omalizumab (LIBERTY-CSU CUPID)

Investigational Site Number : 0320006, Rosario

Investigational Site Number : 3480005, Debrecen

Investigational Site Number : 3480003, Szolnok

Investigational Site Number : 3480004, Szeged

Investigational Site Number : 3480002, Szombathely

Investigational Site Number : 2760001, Berlin

Investigational Site Number : 7240011, Villarreal de Huerva

Investigational Site Number : 7240004, Córdoba

UR Dermatology at College Town Site Number : 8400008, Rochester

Allergy and Clinical Immunology Associates Site Number : 8400024, Pittsburgh

Investigational Site Number : 7240012, Santiago de Compostela

Johns Hopkins University (Asthma and Allergy Center) Site Number : 8400016, Baltimore

Investigational Site Number : 2760007, Kiel

Investigational Site Number : 7240007, Madrid

Investigational Site Number : 7240001, Madrid

Investigational Site Number : 7240006, Madrid

Immunocarolina LLC Site Number : 8400010, Charlotte

National Allergy and ENT Site Number : 8400011, Charleston

Investigational Site Number : 7240002, Pamplona

Aeroallergy Research Laboratories of Savannah, INC Site Number : 8400018, Savannah

Lenus Research & Medical Group Site Number : 8400001, Sweetwater

University of South Florida Site Number : 8400006, Tampa

Sarasota Clinical Research Site Number : 8400017, Sarasota

Investigational Site Number : 7240005, Las Palmas de Gran Canaria

Investigational Site Number : 2500011, Mont-de-Marsan

Allergy & Asthma Specialists, PSC Site Number : 8400020, Owensboro

Investigational Site Number : 2500004, Nantes

Bernstein Clinical Research Center Site Number : 8400014, Cincinnati

Investigational Site Number : 7240013, Burjassot - Valencia

Investigational Site Number : 2760010, Bramsche

Investigational Site Number : 2500002, Lille

Investigational Site Number : 2500009, Calais

The Clinical Research Center, LLC Site Number : 8400009, St Louis

Investigational Site Number : 2500005, Pierre-Bénite

Investigational Site Number : 2760008, Tübingen

Vital Prospects Clinical Research Institute, P.C. Site Number : 8400015, Tulsa

Pharmaceutical Research & Consulting, Inc. Site Number : 8400003, Dallas

Investigational Site Number : 2500006, Paris

STAAMP Research, LLC Site Number : 8400007, San Antonio

California Allergy and Asthma Medical Group, Inc. Site Number : 8400019, Los Angeles

Investigational Site Number : 1560010, Beijing

Investigational Site Number : 1560004, Beijing

Investigational Site Number : 6430005, Moscow

Investigational Site Number : 6430010, Moscow

Investigational Site Number : 6430002, Moscow

Investigational Site Number : 6430003, Saint Petersburg

Investigational Site Number : 1560003, Shanghai

Investigational Site Number : 1560005, Wuxi

Investigational Site Number : 6430004, Smolensk

Investigational Site Number : 1560006, Jinan

Investigational Site Number : 1560002, Hangzhou

Investigational Site Number : 1560008, Hangzhou

Investigational Site Number : 6430007, Krasnodar

Investigational Site Number : 6430001, Stavropol

Investigational Site Number : 6430009, Saratov

Investigational Site Number : 6430006, Kazan'

Investigational Site Number : 6430008, Chelyabinsk

Investigational Site Number : 1560007, Guangzhou

Investigational Site Number : 1560001, Chengdu

Investigational Site Number : 0320008, CABA

Investigational Site Number : 0320004, CABA

Investigational Site Number : 0320007, Rosario

Investigational Site Number : 0320005, Rosario

Investigational Site Number : 0320003, San Miguel de Tucumán

Investigational Site Number : 0320001, Buenos Aires

Investigational Site Number : 1240009, Calgary

Investigational Site Number : 1240010, Edmonton

Investigational Site Number : 1240014, Hamilton

Investigational Site Number : 1240013, Markham

Investigational Site Number : 1240003, Niagara Falls

Investigational Site Number : 1240005, Toronto

Investigational Site Number : 1240002, Toronto

Investigational Site Number : 1240007, Windsor

Investigational Site Number : 1240016, Sherbrooke

Investigational Site Number : 1240006, Trois-Rivières

Investigational Site Number : 1240004, Québec

Investigational Site Number : 1240011, Québec

Investigational Site Number : 2500012, Nice

Investigational Site Number : 2500003, Nice

Investigational Site Number : 2760006, Dresden

Investigational Site Number : 3920005, Hiroshima

Investigational Site Number : 3920009, Sapporo

Investigational Site Number : 3920002, Kobe

Investigational Site Number : 3920011, Kagoshima

Investigational Site Number : 3920013, Yokohama

Investigational Site Number : 3920008, Yokohama

Investigational Site Number : 3920003, Suita-shi

Investigational Site Number : 3920007, Izumo-shi

Investigational Site Number : 3920006, Itabashi-ku

Investigational Site Number : 3920001, Shinagawa-Ku

Investigational Site Number : 3920010, Tachikawa-shi

Investigational Site Number : 3920004, Nagoya

Investigational Site Number : 7240003, Barcelona

Investigational Site Number : 7240008, Barcelona

Investigational Site Number : 7240014, L'Hospitalet de Llobregat

Investigational Site Number : 7240010, Esplugues de Llobregat

Investigational Site Number : 8260002, London

Investigational Site Number : 8260001, Manchester